BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28877081)

  • 1. Safety and Efficacy of Wireless pH Monitoring in Patients Suspected of Gastroesophageal Reflux Disease: A Systematic Review.
    Kessels SJM; Newton SS; Morona JK; Merlin TL
    J Clin Gastroenterol; 2017 Oct; 51(9):777-788. PubMed ID: 28877081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wireless esophageal pH capsule for patients with gastroesophageal reflux disease: a multicenter clinical study.
    Yang XJ; Gan T; Wang L; Liao Z; Tao XH; Shen W; Zhao XY
    World J Gastroenterol; 2014 Oct; 20(40):14865-74. PubMed ID: 25356046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference with daily activities and major adverse events during esophageal pH monitoring with bravo wireless capsule versus conventional intranasal catheter: a systematic review of randomized controlled trials.
    Iluyomade A; Olowoyeye A; Fadahunsi O; Thomas L; Libend CN; Ragunathan K; Fenster J; Vignesh S
    Dis Esophagus; 2017 Feb; 30(3):1-9. PubMed ID: 26952638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 24 Versus 48-hour bravo pH monitoring.
    Chander B; Hanley-Williams N; Deng Y; Sheth A
    J Clin Gastroenterol; 2012 Mar; 46(3):197-200. PubMed ID: 21959323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of two modes of gastroesophageal reflux measuring: conventional esophageal pH monitoring and wireless pH monitoring.
    Azzam RS; Sallum RA; Brandão JF; Navarro-Rodriguez T; Nasi A
    Arq Gastroenterol; 2012; 49(2):107-12. PubMed ID: 22766996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes.
    Domingues GR; Moraes-Filho JP; Domingues AG
    Arq Gastroenterol; 2011; 48(1):24-9. PubMed ID: 21537538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years.
    Croffie JM; Fitzgerald JF; Molleston JP; Gupta SK; Corkins MR; Pfefferkorn MD; Lim JR; Steiner SJ; Dadzie SK
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):559-63. PubMed ID: 18030233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term wireless pH monitoring of the distal esophagus: prolonging the test beyond 48 hours is unnecessary and may be misleading.
    Capovilla G; Salvador R; Spadotto L; Voltarel G; Pesenti E; Perazzolo A; Nicoletti L; Merigliano S; Costantini M
    Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wireless esophageal pH monitoring is better tolerated than the catheter-based technique: results from a randomized cross-over trial.
    Wenner J; Johnsson F; Johansson J; Oberg S
    Am J Gastroenterol; 2007 Feb; 102(2):239-45. PubMed ID: 17100971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wireless pH capsule--yield in clinical practice.
    Roman S; Mion F; Zerbib F; Benamouzig R; Letard JC; Bruley des Varannes S
    Endoscopy; 2012 Mar; 44(3):270-6. PubMed ID: 22275050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oesophageal pH monitoring using the Bravo catheter-free radio capsule.
    Gillies RS; Stratford JM; Booth MI; Dehn TC
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):57-63. PubMed ID: 17206078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility and tolerability of JSPH-1 wireless esophageal pH monitoring system.
    Li JN; Liu CL; Tao XH
    BMC Gastroenterol; 2013 Jan; 13():10. PubMed ID: 23317032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction using the Bravo pH monitoring system.
    Pandolfino JE; Lee TJ; Schreiner MA; Zhang Q; Roth MP; Kahrilas PJ
    Dis Esophagus; 2006; 19(3):177-82. PubMed ID: 16722995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications of 24-h esophageal pH monitoring, capsule pH monitoring, combined pH monitoring with multichannel impedance, esophageal manometry, radiology and scintigraphy in gastroesophageal reflux disease?
    Vardar R; Keskin M
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S16-S21. PubMed ID: 29199161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroesophageal reflux monitoring: pH (catheter and capsule) and impedance.
    Hong SK; Vaezi MF
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):1-22, v. PubMed ID: 19232277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of the wireless pH capsule.
    Lacy BE; Dukowicz AC; Robertson DJ; Weiss JE; Teixeira P; Kelley ML
    J Clin Gastroenterol; 2011; 45(5):429-35. PubMed ID: 21030875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wireless capsule pH monitoring: does it fulfil all expectations?
    Maerten P; Ortner M; Michetti P; Dorta G
    Digestion; 2007; 76(3-4):235-40. PubMed ID: 18174686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
    Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
    Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiographic demonstration of a wireless capsule pH monitor in the esophagus.
    Javors BR; Bukman R
    Dysphagia; 2011 Jun; 26(2):193-5. PubMed ID: 20443028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACG practice guidelines: esophageal reflux testing.
    Hirano I; Richter JE;
    Am J Gastroenterol; 2007 Mar; 102(3):668-85. PubMed ID: 17335450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.